期刊文献+

A protective AAV vaccine for SARS-CoV-2 被引量:1

原文传递
导出
摘要 Dear Editor,Severe acute respiratory syndrome coronavirus-2(SARS-CoV-2)has caused the COVID-19 pandemic,with more than 528 million infections and 6.2 million deaths.To fight against this rapidly spreading pandemic,prophylactic vaccines have been developed using different techniques,such as inactivated virus,messenger RNAs,recombinant proteins,and viral-vectored vaccines.However,rapidly spreading variants of SARS-CoV-2,such as alpha,beta,delta,and omicron variants,have been emerging.
出处 《Signal Transduction and Targeted Therapy》 SCIE CSCD 2022年第10期3641-3644,共4页 信号转导与靶向治疗(英文)
基金 supported by Science and Technology Commission of Shanghai Municipality(YDZX20223100001002) Shanghai Frontiers Science Center for Biomacromolecules and Precision Medicine at ShanghaiTech University,Shanghai Local College Capacity Building Project(22010502700) grants from the National Key Research and Development Program of China(2017YFC1001301(G.Z.),2019YFA0111000(H.W.)) National Natural Science Foundation of China(31871487(C.L.)).
  • 相关文献

参考文献1

二级参考文献4

共引文献6

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部